Details for 2015711122
Up to date per 24.04.2026
Actions
Details for 2015711122
Deleted
European Patent
25.01.2017 A
14.03.2018 B1
18.03.2014
US
201461954715 P
03.07.2014
US
201462020570 P
C07H 17/08 20060101AFI20170921BHEP
Owner
Xellia Pharmaceuticals ApSDalslandsgade 11 2300 Copenhagen SDK
Representative
Representative
Michael Dipl.Ing. Mag. BabelukFlorianigasse 26/31080 WienAT
Inventor
KLUGE, StefanLörracherstrasse 119 4125 RiehenCH